Who Should Consider GLP-1 Weight Loss Treatment
Risk-benefit analysis should consider the severity and impact of the condition being treated, failure or limitations of conventional therapies, individual patient risk factors particularly for malignancy, and patient preferences regarding experimental treatments
However, strict pharmaceutical guidelines limited our capacity to openly discuss and educate about our product and its suitability for consumers
But when I saw people touting glutathione as the Goldilocks of antioxidants, I knew it was worth trying
Primary study measure of hemoglobin A1C levels were assessed at baseline, 6 months, and 12 months after medication assistance program enrollment
This lack of signal in controlled settings provides some reassurance, though it does not definitively exclude the possibility of effects in individual patients or specific subpopulations